Johannes M Engelbrecht

Affiliations
  • Vergelegen Mediclinic, Cape Town, South Africa.

Publications (1)

Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

The Lancet. Respiratory medicine
Avec: Alexander P J Vlaar , Martin Witzenrath , Pieter van Paassen , Leo M A Heunks , Bruno Mourvillier , Sanne de Bruin , Endry H T Lim , Matthijs C Brouwer , Pieter R Tuinman , José F K Saraiva , Gernot Marx , Suzana M Lobo , Rodrigo Boldo , Jesus A Simon-Campos , Alexander D Cornet , Anastasia Grebenyuk , Johannes M Engelbrecht , Murimisi Mukansi , Philippe G Jorens , Robert Zerbib , Simon Rückinger , Korinna Pilz , Renfeng Guo , Diederik van de Beek , Niels C Riedemann , Auteur inconnu

Réseau de co-auteurs

Alexander P J Vlaar 1 collaboration
Martin Witzenrath 1 collaboration
Pieter van Paassen 1 collaboration
Leo M A Heunks 1 collaboration
Bruno Mourvillier 1 collaboration
Sanne de Bruin 1 collaboration
Endry H T Lim 1 collaboration
Matthijs C Brouwer 1 collaboration
Pieter R Tuinman 1 collaboration
José F K Saraiva 1 collaboration
Gernot Marx 1 collaboration
Suzana M Lobo 1 collaboration
Rodrigo Boldo 1 collaboration
Jesus A Simon-Campos 1 collaboration
Alexander D Cornet 1 collaboration
Anastasia Grebenyuk 1 collaboration
Murimisi Mukansi 1 collaboration
Philippe G Jorens 1 collaboration
Robert Zerbib 1 collaboration
Simon Rückinger 1 collaboration
Korinna Pilz 1 collaboration
Renfeng Guo 1 collaboration
Diederik van de Beek 1 collaboration
Niels C Riedemann 1 collaboration
None None 1 collaboration